Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease

[1]  C. Khor,et al.  Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease , 2014, Genome Medicine.

[2]  Yingbin Xiao,et al.  Primary repair of tetralogy of Fallot in infants: transatrial/transpulmonary or transventricular approach. , 2013, Asian journal of surgery.

[3]  Wei-Chiao Chang,et al.  Increased Risk of Atopic Dermatitis in Preschool Children with Kawasaki Disease: A Population-Based Study in Taiwan , 2013, Evidence-based complementary and alternative medicine : eCAM.

[4]  Colin G Fink,et al.  Transcriptomic Profiling in Childhood H1N1/09 Influenza Reveals Reduced Expression of Protein Synthesis Genes , 2013, The Journal of infectious diseases.

[5]  S. Crosby,et al.  Gene expression profiles in febrile children with defined viral and bacterial infection , 2013, Proceedings of the National Academy of Sciences.

[6]  Jinfen Liu,et al.  Label-free quantitative proteomic analysis of right ventricular remodeling in infant Tetralogy of Fallot patients. , 2013, Journal of proteomics.

[7]  L. Formigli,et al.  Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling , 2013, PloS one.

[8]  J. Burns,et al.  The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. , 2013, Human pathology.

[9]  J. Burns,et al.  Incidence of Kawasaki disease in northern European countries , 2012, Pediatrics international : official journal of the Japan Pediatric Society.

[10]  S. Smale,et al.  Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways , 2012, Nature Immunology.

[11]  T. Kuijpers,et al.  A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation , 2012, Annals of the rheumatic diseases.

[12]  K. Kotani,et al.  Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey , 2012, Journal of epidemiology.

[13]  S. Ichinose,et al.  SASPase regulates stratum corneum hydration through profilaggrin-to-filaggrin processing , 2011, EMBO molecular medicine.

[14]  L. Coin,et al.  Transforming Growth Factor-&bgr; Signaling Pathway in Patients With Kawasaki Disease , 2011, Circulation. Cardiovascular genetics.

[15]  M. Iwata,et al.  Cyp26b1 Regulates Retinoic Acid-Dependent Signals in T Cells and Its Expression Is Inhibited by Transforming Growth Factor-β , 2011, PloS one.

[16]  Calvin Lin,et al.  Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. , 2010, Human Immunology.

[17]  Kayoko Sato,et al.  Clinical Score and Transcript Abundance Patterns Identify Kawasaki Disease Patients Who May Benefit From Addition of Methylprednisolone , 2009, Pediatric Research.

[18]  D. Tindall,et al.  Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostate cancer. , 2008, Cancer research.

[19]  J. Abe,et al.  Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease. , 2008, The Journal of allergy and clinical immunology.

[20]  Lanfen Chen,et al.  CEACAM1 and the regulation of mucosal inflammation , 2008, Mucosal Immunology.

[21]  J. Newburger,et al.  Resistance to intravenous immunoglobulin in children with Kawasaki disease. , 2008, The Journal of pediatrics.

[22]  P. Brown,et al.  Gene-expression patterns reveal underlying biological processes in Kawasaki disease , 2007, Genome Biology.

[23]  Giulio Gabbiani,et al.  The myofibroblast: one function, multiple origins. , 2007, The American journal of pathology.

[24]  B. Hinz.  Formation and function of the myofibroblast during tissue repair. , 2007, The Journal of investigative dermatology.

[25]  H. Senzaki.  The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases , 2006, Archives of Disease in Childhood.

[26]  M. Donovan,et al.  Identification and characterization of a novel retroviral-like aspartic protease specifically expressed in human epidermis. , 2005, The Journal of investigative dermatology.

[27]  R. Lutter,et al.  Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases , 2005, Clinical and experimental immunology.

[28]  I. Scheffrahn,et al.  CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand‐induced apoptosis in granulocytes , 2005, European journal of immunology.

[29]  K. Becker,et al.  Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.

[30]  J. Newburger,et al.  Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. , 1998, The Pediatric infectious disease journal.

[31]  K Hashino,et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.

[32]  S. Shulman,et al.  Nationwide survey of Kawasaki disease and acute rheumatic fever. , 1991, The Journal of pediatrics.

[33]  M Takahashi,et al.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. , 1991, The New England journal of medicine.

[34]  J. Newburger,et al.  Increased prevalence of atopic dermatitis in Kawasaki disease. , 1988, The Pediatric infectious disease journal.

[35]  T. Kamiya,et al.  Cardiac biopsy in Kawasaki disease , 1981, Heart and Vessels.

[36]  H. Yanagawa,et al.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.

[37]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[38]  B. Gao,et al.  Adrenomedullin Is Highly Expressed in Blood Monocytes Associated with Acute Kawasaki Disease: A Microarray Gene Expression Study , 2005, Pediatric Research.

[39]  Chris Cheadle,et al.  Application of z-score transformation to Affymetrix data. , 2003, Applied bioinformatics.